Detalles de la búsqueda
1.
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset.
Ann Rheum Dis
; 81(8): 1085-1095, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470158
2.
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Ann Rheum Dis
; 80(11): 1400-1409, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926921
3.
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
Rheumatology (Oxford)
; 60(12): 5549-5559, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748831
4.
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis.
Rheumatology (Oxford)
; 60(SI): SI3-SI12, 2021 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34146099
5.
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Ann Rheum Dis
; 78(2): 192-200, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396903
6.
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Ann Rheum Dis
; 76(8): 1426-1431, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28473425
7.
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.
Ann Rheum Dis
; 79(2): e14, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573653
8.
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.
Ann Rheum Dis
; 79(4): e37, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674476
9.
Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry.
Arthritis Rheum
; 65(5): 1213-23, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23460467
10.
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry.
Ann Rheum Dis
; 72(7): 1149-55, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22941767
11.
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry.
Ann Rheum Dis
; 72(1): 79-82, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22945500
12.
Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry.
Ann Rheum Dis
; 72(1): 57-63, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22532636
13.
Diagnostic Value of Composite and Simplified FDG-PET/CT Scores in Polymyalgia Rheumatica and the Influence of Recent Glucocorticoid Treatment-A Retrospective Diagnostic Cohort Study.
Diagnostics (Basel)
; 13(3)2023 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36766618
14.
Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
J Rheumatol
; 49(10): 1163-1172, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35705237
15.
Nationwide, large-scale implementation of an online system for remote entry of patient-reported outcomes in rheumatology: characteristics of users and non-users and time to first entry.
RMD Open
; 8(2)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36418086
16.
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry.
RMD Open
; 8(2)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36418087
17.
Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
RMD Open
; 7(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33402443
18.
The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO.
Clin Epidemiol
; 8: 737-742, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27822121
19.
Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteoarthritis Study.
Arthritis Res Ther
; 18: 53, 2016 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26912229
20.
Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry.
RMD Open
; 7(2)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33941664